Literature DB >> 557107

Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.

M Ary, B Cox, P Lomax.   

Abstract

Rats were made dependent on morphine by implantation of a pellet and withdrawal was precipitated by the injection of naloxone 72 hours later. Withdrawal was assessed by scoring each of the following signs individually: chewing, licking, teeth chattering, facial tremor, grooming, writhing, diarrhea, weight loss, wet dog shakes, head shakes and hypothermia. The role of dopamine in withdrawal was determined by pretreating the animals with apomorphine or pimozide. Apomorphine in the lower dose range (0.625-1.25 mg/kg) produced a significant decrease in teeth chattering, writhing, weight loss and wet dog shakes. The high dose of apomorphine (2.5 mg/kg) significantly inhibited all features of the withdrawal except writhing and weight loss. Pimozide caused a significant increase in chewing, writhing and head shakes, but only with the highest dose used (0.5 mg/kg). Pimozide (0.5 mg/kg) significantly reduced withdrawal hypothermia, but apomorphine had no effect on this sign except at the highest dose when withdrawal hypothermia was increased.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557107

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Comparison of tolerance development and dependence capacities of morphine, beta-endorphin, and [D-Met2, Pro5]-enkephalinamide.

Authors:  E Miglécz; J I Székely; Z Dunai-Kovács
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Influence of different benzodiazepines on the experimental morphine abstinence syndrome.

Authors:  R Maldonado; J A Micó; O Valverde; M C Saavedra; I Leonsegui; J Gibert-Rahola
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.

Authors:  Sanjay Kasture; Stefania Vinci; Federico Ibba; Alessandro Puddu; Mara Marongiu; Balasubramanian Murali; Augusta Pisanu; Daniele Lecca; Gerald Zernig; Elio Acquas
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

4.  [Comparisons between the effects of apomorphine and naloxone in acutely dependent morphinized rats and mice (author's transl)].

Authors:  E C Tremblay; J J Jacob
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

5.  Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).

Authors:  Seth D Norrholm; Mahasweta Das; Gábor Légrádi
Journal:  Regul Pept       Date:  2005-05-15

6.  Role of brain catecholamines and 5-hydroxytryptamine in morphine induced temperature changes in normal and tolerant rats and mice.

Authors:  P Slater; C Blundell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

7.  Lysergic acid diethylamide antagonizes shaking induced in rats by five chemically different compounds.

Authors:  A Cowan; T Watson
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

8.  Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly).

Authors:  R F Ritzmann; R Walter; H N Bhargava; L B Flexner
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  An electromyographic method for the assessment of naloxone-induced abstinence in morphine-dependent rats.

Authors:  M K Menon; L F Tseng; H H Loh; W G Clark
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

10.  Characterization of the dopamine stimulated adenylate cyclase in the pedal ganglia of Mytilus edulis: interactions with etorphine, beta-endorphin, DALA, and methionine enkephalin.

Authors:  G B Stefano; E J Catapane; R M Kream
Journal:  Cell Mol Neurobiol       Date:  1981-03       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.